During this special season, we want to express our gratitude to all who share with us the commitment to animal health and
Diclacare® 2.5 mg/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group. Diclacare® 2.5 mg/ml
This October, Alivira inaugurated a new global R&D center in Ankara, Turkey. With the opening of this new research facility, Alivira Turkey
Access VetMed held its 23rd Annual CEOs Meeting on the 18th and 19th of September in Barcelona. The event, organized by Alivira
As a regular collaborating company, Alivira once again took part in the ANEMBE International Congress, whose latest edition was held from May
From April 22 to 25, the Alivira group held the third edition of its Global Convention, a key annual strategic event aimed
An Alivira Group Company
P. I. La Borda Mas Pujades 11-12
P. I. La Borda, Borges Blanques 21-25
08140 Caldes de Montbui
Barcelona (Spain)
Usar ese formulario solo para consultas de Farmacovigilancia.
Por favor, no usarlo para otros temas.
